In vitro evaluation of electrochemically bioactivated Ti6Al4V 3D porous scaffolds.


Journal

Materials science & engineering. C, Materials for biological applications
ISSN: 1873-0191
Titre abrégé: Mater Sci Eng C Mater Biol Appl
Pays: Netherlands
ID NLM: 101484109

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 12 10 2020
revised: 28 12 2020
accepted: 03 01 2021
entrez: 13 2 2021
pubmed: 14 2 2021
medline: 15 5 2021
Statut: ppublish

Résumé

Triply periodic minimal surfaces (TPMS) are known for their advanced mechanical properties and are wrinkle-free with a smooth local topology. These surfaces provide suitable conditions for cell attachment and proliferation. In this study, the in vitro osteoinductive and antibacterial properties of scaffolds with different minimal pore diameters and architectures were investigated. For the first time, scaffolds with TPMS architecture were treated electrochemically by plasma electrolytic oxidation (PEO) with and without silver nanoparticles (AgNPs) to enhance the surface bioactivity. It was found that the scaffold architecture had a greater impact on the osteoblast cell activity than the pore size. Through control of the architecture type, the collagen production by osteoblast cells increased by 18.9% and by 43.0% in the case of additional surface PEO bioactivation. The manufactured scaffolds demonstrated an extremely low quasi-elastic modulus (comparable with trabecular and cortical bone), which was 5-10 times lower than that of bulk titanium (6.4-11.4 GPa vs 100-105 GPa). The AgNPs provided antibacterial properties against both gram-positive and gram-negative bacteria and had no significant impact on the osteoblast cell growth. Complex experimental results show the in vitro effectiveness of the PEO-modified TPMS architecture, which could positively impact the clinical applications of porous bioactive implants.

Identifiants

pubmed: 33579496
pii: S0928-4931(21)00008-4
doi: 10.1016/j.msec.2021.111870
pii:
doi:

Substances chimiques

Alloys 0
Anti-Bacterial Agents 0
titanium alloy (TiAl6V4) 12743-70-3
Silver 3M4G523W1G
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111870

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Alexandr Myakinin (A)

D. Serikbayev East Kazakhstan State Technical University, F02K6B2 Oskemen, Kazakhstan.

Amanzhol Turlybekuly (A)

Nazarbayev University, Z05H0P9 Nur-Sultan, Kazakhstan.

Alexander Pogrebnjak (A)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine; al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan.

Adam Mirek (A)

Institut Européen des Membranes, IEM, UMR-5635, University Montpellier, CNRS, ENSCM, 34095 Montpellier CEDEX 5, France; Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, 02-109 Warsaw, Poland.

Mikhael Bechelany (M)

Institut Européen des Membranes, IEM, UMR-5635, University Montpellier, CNRS, ENSCM, 34095 Montpellier CEDEX 5, France.

Iryna Liubchak (I)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine.

Oleksandr Oleshko (O)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine.

Yevheniia Husak (Y)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine.

Viktoriia Korniienko (V)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine.

Katarzyna Leśniak-Ziółkowska (K)

Silesian University of Technology, Faculty of Chemistry, 44-100 Gliwice, Poland.

Dmitry Dogadkin (D)

D. Serikbayev East Kazakhstan State Technical University, F02K6B2 Oskemen, Kazakhstan.

Rafał Banasiuk (R)

NanoWave, 02-676 Warsaw, Poland; Institute of Biotechnology and Molecular Medicine, 80-172 Gdansk, Poland.

Roman Moskalenko (R)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine.

Maksym Pogorielov (M)

Sumy State University, Medical Institute, 40018 Sumy, Ukraine; NanoPrime, 32-900 Dębica, Poland.

Wojciech Simka (W)

Silesian University of Technology, Faculty of Chemistry, 44-100 Gliwice, Poland; NanoPrime, 32-900 Dębica, Poland. Electronic address: wojciech.simka@polsl.pl.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH